These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 4772875)

  • 21. [Physical criteria of pathological processes. III. Structure of the correlation between the level of steady brain potential with serum complement proteins in rheumatic diseases].
    Klimenko LL; Kozlov LV; Kudriashova LP; Protasova OV; Maksimova IA; Komarova MN; Konradov AA; Turna AA; Soiustova EL; Matveev GN
    Biofizika; 1999; 44(1):128-31. PubMed ID: 10330589
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Observation of the third component of complement (C3) and total hemolytic complement (CH50) in serum with SLE].
    Jin A; Chen P; Ke X; Yu M; Fan L; Zhang N; Hou J; Ling Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Oct; 4(5):322-3. PubMed ID: 6219771
    [No Abstract]   [Full Text] [Related]  

  • 23. [Reduced phagocytosis of heat-aggregated human IgG by polymorphonuclear leucocytes from patients with systemic lupus erythematosus (author's transl)].
    Ikebe K; Okawa M; Aotsuka S; Yokohari R
    Ryumachi; 1980 Apr; 20(2):75-81. PubMed ID: 7384948
    [No Abstract]   [Full Text] [Related]  

  • 24. In vitro study of complement dependent active adherence on SLE and RA leukocytes.
    Dénes L; Falus A; Böhm U; Merétey K
    Acta Physiol Acad Sci Hung; 1981; 58(1):21-9. PubMed ID: 7342695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Serum complement activity. Clinical and humoral correlations].
    Purice S; Ghelerter L; Drăgoi T; Lungu N
    Med Interna (Bucur); 1969 Feb; 21(2):173-80. PubMed ID: 5780235
    [No Abstract]   [Full Text] [Related]  

  • 26. [Nonspecific defense mechanism in systemic lupus erythematosus: phagocytosis, adherence and leukocyte peroxidase].
    Diumenjo MS; Rivero I; Vannucci JD
    Rev Clin Esp; 1978 Feb; 148(3):273-7. PubMed ID: 653045
    [No Abstract]   [Full Text] [Related]  

  • 27. [Pathogenesis of complement decrease in the synovial fluid in rheumatoid arthritis and disseminated lupus erythematosus].
    Peltier AP; de Sèze S
    Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):61-8. PubMed ID: 5549169
    [No Abstract]   [Full Text] [Related]  

  • 28. Serum complement, kidney disease and infection in patients with systemic lupus erythematosus.
    Futrakul P; Campbell RA
    J Med Assoc Thai; 1970 May; 53(5):346-8. PubMed ID: 5505655
    [No Abstract]   [Full Text] [Related]  

  • 29. Lupus erythematosus syndrome and complete deficiency of the fourth component of complement.
    Hauptmann G; Grosshans E; Heid E
    Boll Ist Sieroter Milan; 1974; 53(1):suppl:228. PubMed ID: 4212148
    [No Abstract]   [Full Text] [Related]  

  • 30. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L; Hällgren R; Venge P
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunological evaluation of SLE. 2].
    Tomisawa T; Yoneya N; Nakamura M
    Rinsho Byori; 1971 Aug; 19():Suppl:477. PubMed ID: 5316595
    [No Abstract]   [Full Text] [Related]  

  • 32. [Acute lupus erythematosus with total absence of the C4 fraction of complement].
    Hauptmann G; Grosshans E; Heid E; Mayer S; Basset A
    Nouv Presse Med; 1974 Apr; 3(14):881-2. PubMed ID: 4601861
    [No Abstract]   [Full Text] [Related]  

  • 33. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
    Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
    Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
    [No Abstract]   [Full Text] [Related]  

  • 34. Digital ulcers/gangrene and immunoglobulin classes/complement fixation of anti-dsDNA in systemic lupus erythematosus patients.
    Hashimoto H; Tsuda H; Takasaki Y; Fujimaki N; Suzuki M; Shiokawa Y
    J Rheumatol; 1983 Oct; 10(5):727-32. PubMed ID: 6606040
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The importance of determination of interleukin-10 in the blood of patients with systemic lupus erythematosus].
    Scudla V; Horák P; Faltýnek L; Pospísil Z; Budíková M; Hermanová Z
    Cas Lek Cesk; 1998 Jan; 137(2):44-7. PubMed ID: 9511265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complement-mediated solubilization of immune complexes in systemic lupus erythematosus.
    Sakurai T; Fujita T; Kono I; Kabashima T; Yamane K; Tamura N; Kashiwagi H
    Clin Exp Immunol; 1982 Apr; 48(1):37-42. PubMed ID: 6979449
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
    Arora V; Verma J; Dutta R; Marwah V; Kumar A; Das N
    Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Natural cytotoxicity in systemic lupus erythematosus patients].
    Aleksandrova EN; Nasonov EL; Bykhovskaia SIu; Ivanova MM; Solov'ev SK
    Ter Arkh; 1984; 56(5):29-32. PubMed ID: 6463883
    [No Abstract]   [Full Text] [Related]  

  • 39. Inflammatory clearance of apoptotic remnants in systemic lupus erythematosus (SLE).
    Janko C; Schorn C; Grossmayer GE; Frey B; Herrmann M; Gaipl US; Munoz LE
    Autoimmun Rev; 2008 Oct; 8(1):9-12. PubMed ID: 18703173
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pleural effusion in systemic lupus erythematosus.
    Reda MG; Baigelman W
    Acta Cytol; 1980; 24(6):553-7. PubMed ID: 6160709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.